Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein - Wikidata - wikimedia - TriplyDB

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein

http://www.wikidata.org/entity/Q28471835

about

Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011.Avian influenza A H5N1 virus: a continuous threat to humans.Investigational hemagglutinin-targeted influenza virus inhibitors.Inhibitors of influenza viruses replication: a patent evaluation (WO2013019828).Interplay between influenza A virus and host factors: targets for antiviral intervention.How I treat influenza in patients with hematologic malignancies.Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.Drugs in development for influenza.ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION.Antiviral strategies for pandemic and seasonal influenza Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection Using sequence data to infer the antigenicity of influenza virus.Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.A comprehensive map of the influenza A virus replication cycle A safety evaluation of DAS181, a sialidase fusion protein, in rodents.Influenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins.Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults.Management of respiratory viral infections in hematopoietic cell transplant recipients.Influenza A virus entry inhibitors targeting the hemagglutinin.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation Novel hemagglutinin-based influenza virus inhibitors.Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.Influenza virus-host interactomes as a basis for antiviral drug development.Influenza pharmacotherapy: present situation, strategies and hopes.Bitter-sweet symphony: glycan-lectin interactions in virus biology.Antiviral strategies against influenza virus: towards new therapeutic approaches.Screening for Neuraminidase Inhibitory Activity in Traditional Chinese Medicines Used to Treat Influenza.Novel antiviral agents for respiratory viral infection in immunocompromised adults.Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.Treating Influenza Infection, From Now and Into the Future

P2860

Q26853131-3DC45351-48EF-43D2-B591-0BD8FBA12FF1 Q28084005-12490D48-8683-4F00-83CB-469ABD0B63C1 Q28478569-0309F0E0-7716-433D-BFAE-784AF3A6E447 Q30218773-6F49DF22-249B-41A9-88A6-9A96BF475BA5 Q30224462-4E1D7AB8-7B8C-4E29-9A87-677CCD99B452 Q30240175-F4B0B67A-DD03-414D-8922-14B30C9C1AF9 Q30353074-82879A5F-FC8D-49A2-AD73-0115DA51A4D3 Q30375026-AE5CDA24-E7E8-4CDF-BD7A-DB89F1D700C7 Q30383456-358A601D-7595-4216-B914-6081F6A34653 Q30387832-644F9BDE-61C9-4B1D-8015-598B9126D682 Q30391218-98FF9957-9500-4565-BA06-F5042FEE41EC Q30404586-702AF269-350B-45C0-8B9B-007EA3423098 Q30408116-6380F9CA-0363-4412-9EF3-8FAD036B3F44 Q30412678-DFB83F21-D098-4BE1-A050-70345AF0AEA0 Q30422034-AB53D591-FF93-4F6C-82B0-EC599EA48273 Q30652766-BA796537-957C-4718-8B6E-9C56E82366E9 Q33859412-0191391A-955F-4E7B-A993-A9B63985C554 Q34405859-F441E4DE-0482-48E7-9398-F23F270676B4 Q35006697-0272AEE9-2855-405D-A3C1-F70AA00432EA Q35161415-495A91F5-DE7A-4959-8A48-9DB6BC85C93E Q35171172-5B0920C1-97C6-48D6-B989-F0B202185989 Q36264874-B67DD851-EC5D-4AC2-ACD1-E5F4DE8BFA74 Q36439896-2FFCEB98-8E8A-4FA8-8837-4509B3AB7572 Q36586898-3A312E3D-1789-441A-AC28-D9F4A5B57EA5 Q36965855-4E515E34-E327-47ED-8D73-821D2E1DD506 Q37105496-54722347-12A9-4BC6-94F1-B22187CE68BF Q37169942-ABF545FD-AD99-4A3C-905D-4AAE13CBF64A Q37737812-5802CB13-4A68-4A8B-9B2C-10CC4F68D212 Q37857854-8BC0CDC9-CBAE-4403-98BE-9A355EA4A85D Q38159719-1D92D62A-7499-4E31-A795-3ACB25E95061 Q38202012-28A53FC3-8D51-4C37-9DEE-80669D70BB74 Q40585469-7890BEAB-6809-4919-AA12-B90FF48650F7 Q42243405-C7164212-4F29-4C75-8DE9-F7EDEB1D591F Q47549703-DFE54B2D-5DD6-4A00-A20C-DFD84AA38F7C Q57158941-F0562C12-11F4-472F-82B6-1C22A5182F78

P2860

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein

http://www.wikidata.org/entity/Q28471835

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Inhibition of neuraminidase in ...... novel sialidase fusion protein

@ast

Inhibition of neuraminidase in ...... novel sialidase fusion protein

@en

Inhibition of neuraminidase in ...... novel sialidase fusion protein

@nl

type

label

Inhibition of neuraminidase in ...... novel sialidase fusion protein

@ast

Inhibition of neuraminidase in ...... novel sialidase fusion protein

@en

Inhibition of neuraminidase in ...... novel sialidase fusion protein

@nl

prefLabel

Inhibition of neuraminidase in ...... novel sialidase fusion protein

@ast

Inhibition of neuraminidase in ...... novel sialidase fusion protein

@en

Inhibition of neuraminidase in ...... novel sialidase fusion protein

@nl

P1433

Q28471835-ECA913A1-FA45-4C2D-BA1F-E65D4F3B61FC

P1476

Q28471835-40A17F01-54A7-4DB0-8E8A-A3DCD9D06DDE

P2093

Q28471835-02AA3272-419E-46FB-90B3-4DC4CBF2C33B

Q28471835-137729C5-955E-4FB9-A3EA-74E9E2D605FE

Q28471835-25AAEB22-0B38-4893-A48D-2DC2E33F026B

Q28471835-53612F1B-F5B3-466B-A6F3-11743A4416E3

Q28471835-8F5A00FC-F050-46F9-8F77-909661B620A4

Q28471835-9B7C8D03-9DE2-47F6-921F-7CB0EEAFDD88

Q28471835-DF5ED278-5A84-4B69-AE43-D92B606F2287

Q28471835-F3F70408-D07E-4319-8846-1B92D6DEE9AD

Q28471835-FE660E1F-A53E-4C23-AD4C-9B3286A18748

P2860

Q28471835-01C2266C-2584-4D1A-81C7-D0BCC1E4D25D

Q28471835-07C0FC79-CA7A-4EBE-BD0D-DA8265C1FE7E

Q28471835-1F463ED2-6F98-4008-88F5-5918F2AAD24D

Q28471835-245CAF27-CCEC-476E-AB49-7705C58BF794

Q28471835-2ADED2FC-98B9-40D6-B64F-9E71CFC26443

Q28471835-3671B34B-ECDA-4B13-BEB5-C8A90E1CE48F

Q28471835-397B9813-D94E-487A-908E-F58128EF9D2A

Q28471835-3DC099AB-EDFA-4514-9483-F1833E88487F

Q28471835-4239E495-BDF5-450D-8B0B-1E7B5F375D00

Q28471835-48EE712B-1756-46F7-9B56-D03193162C97

P304

Q28471835-3F1CBAFA-05AB-4CB5-B971-00D716AC41B1

P31

Q28471835-F2E38218-57C5-4163-8655-6167DBF05952

P356

Q28471835-266B28BF-09C1-4087-A555-703D6423A4F9

P407

Q28471835-8EBE96ED-0818-4875-9942-B537304EF735

P433

Q28471835-94729F81-7457-430E-9251-45F81B207A5E

P478

Q28471835-532AEFC8-443A-4E06-AB68-4E4F86230047

P577

Q28471835-491FFF9D-602A-4C8F-B3F4-4F00EFC555A7

P5875

Q28471835-41A7C079-9DC3-43FF-BF96-078449FE3099

P698

Q28471835-255EDBC2-C217-4198-82AF-A6F186112A2C

P921

Q28471835-116604C7-5A0C-44DD-8167-F733781C07EF

P932

Q28471835-7324A25C-2619-47A4-B5DC-3EAB9A5A0D1F

P356

JOURNAL.PONE.0007838

P1433

P1476

Inhibition of neuraminidase in ...... novel sialidase fusion protein

@en

P2093

Alexander I Klimov

http://www.w3.org/2001/XMLSchema#string

David F Wurtman

http://www.w3.org/2001/XMLSchema#string

Fang Fang

http://www.w3.org/2001/XMLSchema#string

Gallen B Triana-Baltzer

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Larson

http://www.w3.org/2001/XMLSchema#string

Larisa V Gubareva

http://www.w3.org/2001/XMLSchema#string

Maria Hedlund

http://www.w3.org/2001/XMLSchema#string

Robert B Belshe

http://www.w3.org/2001/XMLSchema#string

Ronald B Moss

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918

Update on avian influenza A (H5N1) virus infection in humans

Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtype

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses

Oseltamivir resistance during treatment of influenza A (H5N1) infection

Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection.

Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.

Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.

P304

e7838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0007838

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38071169

http://www.w3.org/2001/XMLSchema#string

P698

19893749

http://www.w3.org/2001/XMLSchema#string

P921

membrane fusion involved in viral entry into host cell

P932

2770896

http://www.w3.org/2001/XMLSchema#string